AUPH EBITDA
Aurinia Pharmaceuticals Inc · EBITDA
AUPH EBITDA
Latest reported$188.22Mperiod ending
AUPH EBITDA (-$1.95M → $188.22M)
Annual EBITDA
High-resolution chart · PNG
AUPH ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 127,757,000 | |
| 31,728,000 | |
| -63,047,000 | |
| -103,646,000 | |
| -177,445,000 | |
| -102,919,000 | |
| -89,772,000 | |
| -53,927,000 | |
| -45,608,000 | |
| -21,335,000 | |
| -22,022,000 | |
| -15,696,000 | |
| -5,857,000 | |
| -8,936,119 | |
| -1,692,967 | |
| -4,264,944 | |
| -5,201,337 | |
| -14,216,927 | |
| -34,119,964 | |
| -22,602,093 | |
| -28,153,091 | |
| -20,832,016 | |
| -9,829,037 | |
| -861,965 | |
| -7,198,583 | |
| -6,329,180 | |
| -1,086,558 | |
| -1,953,125 |